Search Results - "Trastulli, F."

Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease by Mauro, F R, Chauvie, S, Paoloni, F, Biggi, A, Cimino, G, Rago, A, Gentile, M, Morabito, F, Coscia, M, Bellò, M, Sacchetti, G M, Rossi, D, Laurenti, L, Autore, F, Campanelli, M, Trastulli, F, Nicolai, E, Riminucci, M, Gaidano, G, Guarini, A, Gallamini, A, Foà, R

“…In order to evaluate the predictive value of positron emission tomography–computed tomography (PET/CT) in discriminating the presence of a Richter’s syndrome…”
Get full text

Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi‐Center Real‐Life Study by Picardi, M., Vincenzi, A., Giordano, C., Fazio, L. De, Pugliese, N., Scarpa, A., Vigliar, E., Troncone, G., Russo, D., Mascolo, M., Esposito, G., Prastaro, M., Santoro, C., Esposito, R., Tocchetti, C. G., Mainolfi, C., Fonti, R., Vecchio, S. Del, Carchia, M., Quagliano, C., Salemme, A., Damiano, V., Bianco, R., Trastulli, F., Ronconi, F., Annunziata, M., Pane, F.

“…ABSTRACT In elderly patients with high‐risk classic Hodgkin lymphoma (c‐HL), we evaluated the impact of a new modality treatment without bleomycin, that is,…”
Get full text

(1-3)-β-d-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations by Picardi, M., Della Pepa, R., Giordano, C., Pugliese, N., Mortaruolo, C., Trastulli, F., Grimaldi, F., Zacheo, I., Raimondo, M., Sirignano, C., Salvatore, P., Pane, F.

Get full text

Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma by Picardi, M., Della Pepa, R., Giordano, C., Pugliese, N., Mortaruolo, C., Trastulli, F., Rascato, M.G., Cappuccio, I., Raimondo, M., Memoli, M., Monteverde, M., Mascolo, M., Pane, F.

“…We evaluated the impact on progression-free survival (PFS) of achieving a deep metabolic response at 2-deoxy-2[18F] fluoro-d-glucose positron emission…”
Get full text

PB1995: SAFETY OF SUBCUTANEOUS DARATUMUMAB IN MULTIPLE MYELOMA: A RETROSPECTIVE MULTI‐CENTER REAL LIFE EXPERIENCE by De Novellis, D., Carobene, A., Fontana, R., Mettivier, L., Trastulli, F., Rocco, S., Palmieri, S., Di Perna, M., Pagano, A., Giudice, V., Califano, C., Ferrara, F., Selleri, C.

Get full text

P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA by Iula, R, Trastulli, F, Della Pepa, R, D'Ambrosio, A, Romano, M, Leone, A, Gaeta, G, Palmieri, S, Rocco, S, Pane, F, Ferrara, F, Catalano, L

Get full text

PB1956 COEXISTENCE OF BCR/ABL1 AND JAK2 MUTATION IN MYELOPROLIFERATIVE NEOPLASMS by Luciano, L., Crisci, S., Trastulli, F., Fatigati, M., Izzo, B., Pane, F., Frigeri, F.

“…Background: Chronic Myeloid Leukemia and Myeloproliferative neoplasms were considered mutually exclusive. However some recent reports have described the…”
Get full text